A phase 1b/2 randomized controlled trial examined obinutuzumab specifically in patients with active lupus nephritis.

In this small cohort of adolescents with severe and/or refractory AAV, no drug-induced liver injuries nor opportunistic or serious infections were reported following treatment with avacopan.

Most ION events occurred in men, patients 50 years or older, with minimal risk seen in women, patients younger than 50 years.

The FDA has granted traditional approval to Fabhalta (iptacopan) to slow kidney function decline in adults with primary IgA nephropathy at risk of progression.

A systematic review and meta-analysis analyzed the effects of SGLT2 inhibitors on erythropoiesis and iron homeostasis.

A real-world study sought to evaluate potential effects of renin angiotensin system inhibitors (RASi) during lupus nephritis induction therapy.

The FDA has granted Priority Review to Genentech’s sBLA for obinutuzumab (Gazyva) to treat primary membranous nephropathy, based on phase 3 MAJESTY data.

A scientific statement from the American Heart Association explores strategies for optimizing heart failure care among older adults.

Approximate doubling of maximum plasma concentration and AUC to the last measurable concentration induced by RYGB, SG.

MACE risks during the first 3 years of hemodialysis were lower for users of nondialyzable β-blockers. For patients with end-stage kidney disease (ESKD) initiating hemodialysis, the risk for major ...

Investigators sought to model the effects of relabeling GG1 prostate cancer as precancerous on prostate cancer mortality in the US.